Stepwise evaluation of syncope: a prospective population-based controlled study.
BACKGROUND
Evaluation of syncope remains often unstructured. The aim of the study was to assess the effectiveness of a standardized protocol designed to improve the diagnosis of syncope.


METHODS
Consecutive patients with syncope presenting to the emergency departments of two primary and tertiary care hospitals over a period of 18 months underwent a two-phase evaluation including: 1) noninvasive assessment (phase I); and 2) specialized tests (phase II), if syncope remained unexplained after phase I. During phase II, the evaluation strategy was alternately left to physicians in charge of patients (control), or guided by a standardized protocol relying on cardiac status and frequency of events (intervention). The primary outcomes were the diagnostic yield of each phase, and the impact of the intervention (phase II) measured by multivariable analysis.


RESULTS
Among 1725 patients with syncope, 1579 (92%) entered phase I which permitted to establish a diagnosis in 1061 (67%) of them, including mainly reflex causes and orthostatic hypotension. Five-hundred-eighteen patients (33%) were considered as having unexplained syncope and 363 (70%) entered phase II. A cause for syncope was found in 67 (38%) of 174 patients during intervention periods, compared to 18 (9%) of 189 during control (p<0.001). Compared to control periods, intervention permitted diagnosing more cardiac (8%, vs 3%, p=0.04) and reflex syncope (25% vs 6%, p<0.001), and increased the odds of identifying a cause for syncope by a factor of 4.5 (95% CI: 2.6-8.7, p<0.001). Overall, adding the diagnostic yield obtained during phase I and phase II (intervention periods) permitted establishing the cause of syncope in 76% of patients.


CONCLUSIONS
Application of a standardized diagnostic protocol in patients with syncope improved the likelihood of identifying a cause for this symptom. Future trials should assess the efficacy of diagnosis-specific therapy.
Sarasin
François P
FP
Emergency Center, Hopital Cantonal, University of Geneva Medical School, Geneva, Switzerland. francois.sarasin@hcuge.ch
Pruvot
Etienne
E
Louis-Simonet
Martine
M
Hügli
Olivier W
OW
Sztajzel
Juan M
JM
Schläpfer
Jürg
J
Herrera
Monica
M
Graz
Johan
J
Berchier
Christophe
C
Mischler
Corinne
C
Yersin
Bertrand
B
D000368:Aged; D016009:Chi-Square Distribution; D015897:Comorbidity; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D011159:Population Surveillance; D011446:Prospective Studies; D013575:Syncope / Q000175:diagnosis* / Q000209:etiology* / Q000401:mortality; D016896:Treatment Outcome